ProductLife Group acquires Outcomes'10 to expand market access and evidence services
ProductLife Group (PLG) has acquired Outcomes'10, a Spanish consultancy known for its work in patient access and evidence generation. The move strengthens PLG’s ability to support life sciences companies across Europe as healthcare systems, policies, and expectations continue to evolve. It’s a practical step: more local expertise, more complete services, and a clearer route from evidence to access.
Outcomes'10: experience rooted in Spain, applied to access
With more than 15 years in the field, Outcomes'10 has earned a reputation as a reliable partner for market access in Spain. The team’s core work spans pricing and reimbursement strategies, health economics, outcomes research, and real-world data generation—exactly the capabilities sponsors rely on to bring therapies to patients and keep them there. By welcoming Outcomes'10, PLG continues building a broader, more connected market access platform that can support clients locally while aligning with global plans.
Expanding through integration: Italy, Australia, and now Spain
The Outcomes'10 acquisition follows the integration of Intexo in Italy and Commercial Eyes in Australia. Together, these moves reflect a deliberate approach: assemble strong, on-the-ground expertise in key markets and connect it through a global framework. With these resources working in concert, PLG aims to help clients navigate different healthcare systems, coordinate evidence generation, and shape access strategies that make sense country by country—yet still add up internationally.
What leaders are saying
Luis Lizán, the Founder and CEO of Outcomes'10, framed the partnership as a natural next step: "Joining PLG marks a pivotal moment for our team and clients, allowing us to continue focusing on professional and operational excellence. This collaboration is essential as we face an increasing need for international market access services driven by health science innovations and changing regulations. We are excited about the opportunities this partnership heralds for growth and collaboration."
From PLG’s side, CEO Xavier Duburcq emphasized how the acquisition both broadens the group’s services and sharpens its position in Europe. Outcomes'10 brings deep insight into the Spanish market—knowledge that can help tailor strategies to regional realities while supporting larger product and portfolio plans.
Deepening market access know?how and execution
PLG’s market access team will draw on Outcomes'10’s experience to reinforce its consulting and delivery capabilities. As Mariangela Prada, Market Access BU Head at PLG, put it: "The acquisition of Outcomes'10 signifies a crucial step in enhancing our global market access capabilities. Their expertise and insights into the Spanish market will play a vital role in the ongoing development of our consulting offerings." That focus on practical insight—pricing pathways, evidence packages, local engagement, real?world data—supports a shared goal: clearer routes to patient access, designed with flexibility and built to last.
About ProductLife Group
ProductLife Group helps ensure patients can access effective healthcare solutions by providing consulting and outsourcing services across the product lifecycle. With a footprint that spans over 150 countries, PLG serves as a strategic partner to life sciences organizations as they develop products, enter markets, and manage post?launch obligations. The group’s emphasis on innovation, cost?efficiency, and long?term partnerships reflects a steady aim: deliver value while keeping pace with changing science and policy.
Looking ahead in Europe
Healthcare in Europe keeps shifting—new evidence requirements, evolving reimbursement frameworks, and tighter scrutiny on outcomes. PLG’s response is to strengthen capabilities where it matters most, close to the decisions that shape access. Acquisitions like Outcomes'10 are part of that plan: local expertise connected to a global network, so clients can move with confidence from evidence to access to ongoing value.
Frequently Asked Questions
What does PLG’s acquisition of Outcomes'10 change in practice?
It adds seasoned Spanish market access and evidence expertise to PLG’s global offering, helping clients navigate pricing, reimbursement, and real?world evidence needs across Europe with stronger local insight.
How long has Outcomes'10 operated in the market?
Outcomes'10 has been active for over 15 years, building a solid track record in Spain across market access and evidence generation services.
Which services does Outcomes'10 bring to PLG?
The team specializes in pricing and reimbursement strategies, health economics, outcomes research, and real?world data generation—capabilities that support patient access from early planning through post?launch.
Who are the key PLG leaders mentioned?
PLG’s leadership in this announcement includes CEO Xavier Duburcq and Market Access BU Head Mariangela Prada, who outlined the strategic fit and next steps for market access services.
How will the integration benefit clients outside Spain?
PLG plans to apply Outcomes'10’s Spanish insights across regions as part of a connected, global platform, complementing recent integrations in Italy and Australia to address local needs within a coordinated international strategy.
